Debate Continues on Optimal Neoadjuvant Regimen in Resectable Pancreatic Cancer
Published: Thursday, Apr 02, 2020
Michael Choti, MD
Radiation therapy is not an essential component of neoadjuvant therapy for patients with resectable pancreatic cancer, according to Michael A. Choti, MD, MBA, FACS, who added that chemotherapy is the main treatment that should be used.
... to read the full story